Aliphatic nitrogen-containing 5-membered ring compound

Details for Australian Patent Application No. 2004237882 (hide)

Owner Tanabe Seiyaku Co., Ltd.

Inventors Morimoto, Hiroshi; Matsumoto, Takeshi; Kawanami, Saburo; Hikota, Masataka; Arakawa, Kenji; Yasuda, Kosuke

Agent Spruson & Ferguson

Pub. Number AU-A-2004237882

Parent 2001294197

Filing date 13 December 2004

Wipo publication date 6 January 2005

International Classifications

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 031/428 - condensed with carbocyclic rings

A61K 031/423 - condensed with carbocyclic rings

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61K 031/519 - ortho- or peri-condensed with heterocyclic rings

A61K 031/401 - Proline

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

A61K 031/454

A61K 031/4025 - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 031/327 - Peroxy compounds, e.g. hydroperoxides, peroxides, peroxy acids

A61K 031/433 - Thiadiazoles

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/541 - Non-condensed thiazines containing further heterocyclic rings

A61K 031/437

A61K 031/4725

A61K 031/4365

A61K 031/4035

A61K 031/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 031/4155 - not condensed and containing further heterocyclic rings

C07D 277/06 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/42 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 277/82 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61P 043/00 Drugs for specific purposes, not provided for in groups

A61P 003/10 Drugs for disorders of the metabolism

A61K 031/498 - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

C07D 401/12 Heterocyclic compounds containing two or more hetero rings

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 491/048 Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 495/04 Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

C07D 409/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61K 031/4439

A61K 031/506 - not condensed and containing further heterocyclic rings

Event Publications

6 January 2005 Application Open to Public Inspection

  Published as AU-A-2004237882

6 January 2005 Complete Application Filed

6 March 2008 Alteration of Name

  The name of the applicant has been altered to Mitsubishi Tanabe Pharma Corporation

25 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004237883-Spliceosome mediated RNA transsplicing

2004237881-Power source for high current welding